Structure-activity relationships for α-calcitonin gene-related peptide

British Journal of Pharmacology

Volumn 170, Issue 7, 2013, Pages 1308-1322

  Watkins, Harriet A ^b,c   Rathbone, Dan L ^a   Barwell, James ^a   Hay, Debbie L ^b,c   Poyner, David R ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c MAURICE WILKINS CENTRE FOR MOLECULAR BIODISCOVERY   (New Zealand)

Author keywords

adrenomedullin; amylin; calcitonin; CGRP; domain; GPCR; helix cap; juxtamembrane domain; RAMP; receptor activation; receptor activity modifying protein

Indexed keywords

ALANINE; ALPHA CALCITONIN GENE RELATED PEPTIDE; ARGININE; CALCITONIN RECEPTOR LIKE RECEPTOR; GLYCINE; LIGAND; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; SERINE; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN RECEPTOR; PROTEIN BINDING;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; ENZYME ACTIVITY; LIGAND BINDING; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RECEPTOR BINDING; REVIEW; STRUCTURE ACTIVITY RELATION; AMINO ACID SEQUENCE; ANIMAL; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CALCITONIN GENE-RELATED PEPTIDE; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTOR ACTIVITY-MODIFYING PROTEIN 1; RECEPTORS, CALCITONIN; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84884833625     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12072     Document Type: Review

References (77)

1. Archbold JK, Flanagan JU, Watkins HA, Gingell JJ, Hay DL, (2011). Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development. Trends Pharmacol Sci 32: 591-600.
2. Bailey RJ, Hay DL, (2006). Pharmacology of the human CGRP1 receptor in Cos 7 cells. Peptides 27: 1367-1375.
3. Bailey RJ, Bradley JW, Poyner DR, Rathbone DL, Hay DL, (2010). Functional characterization of two human receptor activity-modifying protein 3 variants. Peptides 31: 579-584.
4. Barwell J, Miller PS, Donnelly D, Poyner DR, (2010). Mapping interaction sites within the N-terminus of the calcitonin gene-related peptide receptor; the role of residues 23-60 of the calcitonin receptor-like receptor. Peptides 31: 170-176.
5. Barwell J, Gingell JJ, Watkins HA, Archbold JK, Poyner DR, Hay DL, (2011). Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs? Br J Pharmacol 166: 51-65.
6. Barwell J, Woolley MJ, Wheatley M, Conner AC, Poyner DR, (2012). The role of the extracellular loops of the CGRP receptor, a family B GPCR. Biochem Soc Trans 40: 433-437.
7. Boeglin D, Hamdan FF, Melendez RE, Cluzeau J, Laperriere A, Heroux M, et al. (2007). Calcitonin gene-related peptide analogues with aza and indolizidinone amino acid residues reveal conformational requirements for antagonist activity at the human calcitonin gene-related peptide 1 receptor. J Med Chem 50: 1401-1408.
8. Boulanger Y, Khiat A, Chen Y, Senecal L, Tu YS, Pierre S, et al. (1995). Structure of human calcitonin gene-related peptide (hCGRP) and of its antagonist hCGRP 8-37 as determined by NMR and molecular modeling. Pept Res 8: 206-213.
9. Boulanger Y, Khiat A, Larocque A, Fournier AS, Pierre S, (1996). Structural comparison of alanine-substituted analogues of the calcitonin gene-related peptide 8-37. Importance of the C-terminal segment for antagonistic activity. Int J Pept Protein Res 47: 477-483.
10. Brain SD, Grant AD, (2004). Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84: 903-934.
11. Breeze AL, Harvey TS, Bazzo R, Campbell ID, (1991). Solution structure of human calcitonin gene-related peptide by 1H NMR and distance geometry with restrained molecular dynamics. Biochemistry 30: 575-582.
12. Carpenter KA, Schmidt R, von, Mentzer B, Haglund U, Roberts E, Walpole C, (2001). Turn structures in CGRP C-terminal analogues promote stable arrangements of key residue side chains. Biochemistry 40: 8317-8325.
13. Chiba T, Yamaguchi A, Yamatani T, Nakamura A, Morishita T, Inui T, et al. (1989). Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am J Physiol 256 (2 Pt 1): E331-E335.
14. Christopoulos G, Perry KJ, Morfis M, Tilakaratne N, Gao Y, Fraser NJ, et al. (1999). Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 56: 235-242.
15. Couvineau A, Laburthe M, (2011). VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins. Br J Pharmacol 166: 42-50.
16. Dennis T, Fournier A, St Pierre S, Quirion R, (1989). Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J Pharmacol Exp Ther 251: 718-725.
17. Dennis T, Fournier A, Cadieux A, Pomerleau F, Jolicoeur FB, St Pierre S, et al. (1990). hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther 254: 123-128.
18. Devigny C, Perez-Balderas F, Hoogeland B, Cuboni S, Wachtel R, Mauch CP, et al. (2011). Biomimetic screening of class-B G protein-coupled receptors. J Am Chem Soc 133: 8927-8933.
19. Durham PL, Vause CV, (2010). Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine. CNS Drugs 24: 539-548.
20. Eguchi S, Hirata Y, Iwasaki H, Sato K, Watanabe TX, Inui T, et al. (1994). Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. Endocrinology 135: 2454-2458.
21. Garber AJ, (2012). Novel GLP-1 receptor agonists for diabetes. Expert Opin Investig Drugs 21: 45-57.
22. ter Haar E, Koth CM, Abdul-Manan N, Swenson L, Coll JT, Lippke JA, et al. (2010). Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure 18: 1083-1093.
23. Hakala JM, Valo T, Vihavainen S, Hermonen J, Heino P, Halme M, et al. (1994). Constrained analogues of the calcitonin gene-related peptide. Biochem Biophys Res Commun 202: 497-503.
24. Hashimoto Y, Toma K, Nishikido J, Yamamoto K, Haneda K, Inazu T, et al. (1999). Effects of glycosylation on the structure and dynamics of eel calcitonin in micelles and lipid bilayers determined by nuclear magnetic resonance spectroscopy. Biochemistry 38: 8377-8384.
25. Hay DL, Howitt SG, Conner AC, Doods H, Schindler M, Poyner DR, (2002). A comparison of the actions of BIBN4096BS and CGRP(8-37) on CGRP and adrenomedullin receptors expressed on SK-N-MC, L6, Col 29 and Rat 2 cells. Br J Pharmacol 137: 80-86.
26. Hay DL, Poyner DR, Quirion R, (2008). International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor. Pharmacol Rev 60: 143-145.
27. Heino P, Oksala O, Palkama A, Valo T, Vihavainen S, Koskinen A, et al. (1998). Binding of CGRP analogs and their effect on adenylate cyclase activity in porcine iris-ciliary body. J Ocul Pharmacol Ther 14: 543-554.
28. Hoare SR, (2005). Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors. Drug Discov Today 10: 417-427.
29. Howitt SG, Poyner DR, (1997). The selectivity and structural determinants of peptide antagonists at the CGRP receptor of rat, L6 myocytes. Br J Pharmacol 121: 1000-1004.
30. Howitt SG, Kilk K, Wang Y, Smith DM, Langel U, Poyner DR, (2003). The role of the 8-18 helix of CGRP8-37 in mediating high affinity binding to CGRP receptors; coulombic and steric interactions. Br J Pharmacol 138: 325-332.
31. Hubbard JA, Martin SR, Chaplin LC, Bose C, Kelly SM, Price NC, (1991). Solution structures of calcitonin-gene-related-peptide analogues of calcitonin-gene-related peptide and amylin. Biochem J 275 (Pt 3): 785-788.
32. Inooka H, Ohtaki T, Kitahara O, Ikegami T, Endo S, Kitada C, et al. (2001). Conformation of a peptide ligand bound to its G-protein coupled receptor. Nat Struct Biol 8: 161-165.
33. Kuwasako K, Kitamura K, Nagata S, Hikosaka T, Takei Y, Kato J, (2011). Shared and separate functions of the RAMP-based adrenomedullin receptors. Peptides 32: 1540-1550.
34. Ladram A, Besne I, Breton L, de, Lacharriere O, Nicolas P, Amiche M, (2008). Pharmacologic study of C-terminal fragments of frog skin calcitonin gene-related peptide. Peptides 29: 1150-1156.
35. Lang M, De Pol S, Baldauf C, Hofmann HJ, Reiser O, Beck-Sickinger AG, (2006). Identification of the key residue of calcitonin gene related peptide (CGRP) 27-37 to obtain antagonists with picomolar affinity at the CGRP receptor. J Med Chem 49: 616-624.
36. Li J, Matsuura JE, Waugh DJ, Adrian TE, Abel PW, Manning MC, et al. (1997). Structure-activity studies on position 14 of human alpha-calcitonin gene-related peptide. J Med Chem 40: 3071-3076.
37. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, et al. (1998). RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393: 333-339.
38. Maggi CA, Rovero P, Giuliani S, Evangelista S, Regoli D, Meli A, (1990). Biological activity of N-terminal fragments of calcitonin gene-related peptide. Eur J Pharmacol 179: 217-219.
39. Mallee JJ, Salvatore CA, LeBourdelles B, Oliver KR, Longmore J, Koblan KS, et al. (2002). Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists. J Biol Chem 277: 14294-14298.
40. Matsuura J, Manning MC, (1993). Conformation of human calcitonin gene-related peptide (8-37) in aqueous solution as determined by circular dichroism spectroscopy. J Pharm Biomed Anal 11: 89-93.
41. Mimeault M, Fournier A, Dumont Y, St-Pierre S, Quirion R, (1991). Comparative affinities and antagonistic potencies of various human calcitonin gene-related peptide fragments on calcitonin gene-related peptide receptors in brain and periphery. J Pharmacol Exp Ther 258: 1084-1090.
42. Mimeault M, Quirion R, Dumont Y, St-Pierre S, Fournier A, (1992). Structure-activity study of hCGRP8-37, a calcitonin gene-related peptide receptor antagonist. J Med Chem 35: 2163-2168.
43. Miranda LP, Holder JR, Shi L, Bennett B, Aral J, Gegg CV, et al. (2008). Identification of potent, selective, and metabolically stable peptide antagonists to the calcitonin gene-related peptide (CGRP) receptor. J Med Chem 51: 7889-7897.
44. Moore EL, Gingell JJ, Kane SA, Hay DL, Salvatore CA, (2010). Mapping the CGRP receptor ligand binding domain: Tryptophan-84 of RAMP1 is critical for agonist and antagonist binding. Biochem Biophys Res Commun 394: 141-145.
45. Nanga RP, Brender JR, Vivekanandan S, Ramamoorthy A, (2011). Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment. Biochim Biophys Acta 1808: 2337-2342.
46. Negro A, Lionetto L, Simmaco M, Martelletti P, (2012). CGRP receptor antagonists: an expanding drug class for acute migraine? Expert Opin Investig Drugs 21: 807-818.
47. Neumann JM, Couvineau A, Murail S, Lacapere JJ, Jamin N, Laburthe M, (2008). Class-B GPCR activation: is ligand helix-capping the key? Trends Biochem Sci 33: 314-319.
48. O'Connell JP, Kelly SM, Raleigh DP, Hubbard JA, Price NC, Dobson CM, et al. (1993). On the role of the C-terminus of alpha-calcitonin-gene-related peptide (alpha CGRP). The structure of des-phenylalaninamide37-alpha CGRP and its interaction with the CGRP receptor. Biochem J 291 (Pt 1): 205-210.
49. Ogoshi M, Inoue K, Naruse K, Takei Y, (2006). Evolutionary history of the calcitonin gene-related peptide family in vertebrates revealed by comparative genomic analyses. Peptides 27: 3154-3164.
50. Parthier C, Kleinschmidt M, Neumann P, Rudolph R, Manhart S, Schlenzig D, et al. (2007). Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor. Proc Natl Acad Sci U S A 104: 13942-13947.
51. Parthier C, Reedtz-Runge S, Rudolph R, Stubbs MT, (2009). Passing the baton in class B GPCRs: peptide hormone activation via helix induction? Trends Biochem Sci 34: 303-310.
52. Patil SM, Xu S, Sheftic SR, Alexandrescu AT, (2009). Dynamic alpha-helix structure of micelle-bound human amylin. J Biol Chem 284: 11982-11991.
53. Perez-Castells J, Martin-Santamaria S, Nieto L, Ramos A, Martinez A, Pascual-Teresa B, et al. (2012). Structure of micelle-bound adrenomedullin: a first step toward the analysis of its interactions with receptors and small molecules. Biopolymers 97: 45-53.
54. Pioszak AA, Xu HE, (2008). Molecular recognition of parathyroid hormone by its G protein-coupled receptor. Proc Natl Acad Sci U S A 105: 5034-5039.
55. Pioszak AA, Parker NR, Gardella TJ, Xu HE, (2009). Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides. J Biol Chem 284: 28382-28391.
56. Poyner DR, (1992). Calcitonin gene-related peptide: multiple actions, multiple receptors. Pharmacol Ther 56: 23-51.
57. Poyner DR, Andrew DP, Brown D, Bose C, Hanley MR, (1992). Pharmacological characterization of a receptor for calcitonin gene-related peptide on rat, L6 myocytes. Br J Pharmacol 105: 441-447.
58. Poyner DR, Soomets U, Howitt SG, Langel U, (1998). Structural determinants for binding to CGRP receptors expressed by human SK-N-MC and Col 29 cells: studies with chimeric and other peptides. Br J Pharmacol 124: 1659-1666.
59. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, et al. (2002). International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54: 233-246.
60. Prado MA, Evans-Bain B, Dickerson IM, (2002). Receptor component protein (RCP): a member of a multi-protein complex required for G-protein-coupled signal transduction. Biochem Soc Trans 30: 460-464.
61. Qi T, Dong M, Watkins HA, Wootten D, Miller LJ, Hay DL, (2012). Receptor activity-modifying protein dependent impairment of calcitonin receptor splice variant Delta(1-47)hCT((a)) function. Br J Pharmacol 168: 644-657.
62. Rist B, Entzeroth M, Beck-Sickinger AG, (1998). From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor. J Med Chem 41: 117-123.
63. Rist B, Lacroix JS, Entzeroth M, Doods HN, Beck-Sickinger AG, (1999). CGRP 27-37 analogues with high affinity to the CGRP1 receptor show antagonistic properties in a rat blood flow assay. Regul Pept 79: 153-158.
64. Robinson SD, Aitken JF, Bailey RJ, Poyner DR, Hay DL, (2009). Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3. J Pharmacol Exp Ther 331: 513-521.
65. Rovero P, Giuliani S, Maggi CA, (1992). CGRP antagonist activity of short C-terminal fragments of human alpha CGRP, CGRP(23-37) and CGRP(19-37). Peptides 13: 1025-1027.
66. Runge S, Thogersen H, Madsen K, Lau J, Rudolph R, (2008). Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. J Biol Chem 283: 11340-11347.
67. Sagoo JK, Bose C, Beeley NR, Tendler SJ, (1991). Structural studies on the [Bu(t)-Cys18](19-37)-fragment of human beta-calcitonin-gene-related peptide. Biochem J 280 (Pt 1): 147-150.
68. Shimizu M, Potts JT, Jr, Gardella TJ, (2000). Minimization of parathyroid hormone. Novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor. J Biol Chem 275: 21836-21843.
69. Smith DD, Saha S, Fang G, Schaffert C, Waugh DJ, Zeng W, et al. (2003). Modifications to the N-terminus but not the C-terminus of calcitonin gene-related peptide(8-37) produce antagonists with increased affinity. J Med Chem 46: 2427-2435.
70. Stangl D, Muff R, Schmolck C, Fischer JA, (1993). Photoaffinity labeling of rat calcitonin gene-related peptide receptors and adenylate cyclase activation: identification of receptor subtypes. Endocrinology 132: 744-750.
71. Tippins JR, Di Marzo V, Panico M, Morris HR, MacIntyre I, (1986). Investigation of the structure/activity relationship of human calcitonin gene-related peptide (CGRP). Biochem Biophys Res Commun 134: 1306-1311.
72. Underwood CR, Garibay P, Knudsen LB, Hastrup S, Peters GH, Rudolph R, et al. (2010). Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor. J Biol Chem 285: 723-730.
73. van Valen F, Keck E, Jurgens H, (1989). Functional characteristics of calcitonin gene-related peptide receptors in human Ewing's sarcoma WE-68 cells. FEBS Lett 256: 170-174.
74. Watkins HA, Au M, Bobby R, Williams G, Abdul Manan N, Archbold J, et al. (2011). Adrenomedullin: a structural paradigm shift in class B G-protein coupled receptor peptide hormones? Proceedings of the British Pharmacological Society. Available at: http://www.pA2online.org/abstracts/Vol9Issue3abst070P.pdf (accessed 2/25/2013).
75. Watkins HA, Au M, Hay DL, (2012). The structure of secretin family GPCR peptide ligands: implications for receptor pharmacology and drug development. Drug Discov Today 17: 1006-1014.
76. Wisskirchen FM, Doyle PM, Gough SL, Harris CJ, Marshall I, (2000). Bioactive beta-bend structures for the antagonist halpha CGRP(8-37) at the CGRP(1) receptor of the rat pulmonary artery. Br J Pharmacol 129: 1049-1055.
77. Yan LZ, Johnson KW, Rothstein E, Flora D, Edwards P, Li B, et al. (2011). Discovery of potent, cyclic calcitonin gene-related peptide receptor antagonists. J Pept Sci 17: 383-386.